GeneDx Holdings
112 hedge funds and large institutions have $487M invested in GeneDx Holdings in 2021 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 39 increasing their positions, 16 reducing their positions, and 15 closing their positions.
173% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 15
144% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 16
40% more call options, than puts
Call options by funds: $7.16M | Put options by funds: $5.11M
30% more funds holding
Funds holding: 86 → 112 (+26)
0.03% less ownership
Funds ownership: 1.41% → 1.38% (-0.03%)
42% less capital invested
Capital invested by funds: $842M → $487M (-$355M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| 1 |
TP
Third Point
New York
|
+$10.2M |
| 2 |
Renaissance Technologies
New York
|
+$6.72M |
| 3 |
Millennium Management
New York
|
+$6.71M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$6.07M |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$4.84M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
Osaic Holdings
Scottsdale,
Arizona
| – | -$223 | -1 | -33% |
|
|
SCA
127
Snowden Capital Advisors
New York
| – | +$223 | +1 | New |
|
WGS Hedge Fund Activity: Q4 2021 in Review
112 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q4 2021, worth a combined $487M — down 42% from $842M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new WGS positions and 15 closed out — a net gain of 26 holders — while 39 added to existing stakes and 16 trimmed.
The largest buyer was Third Point, adding an estimated $10.2M. The largest seller was ARK Investment Management, exiting entirely with an estimated $71.3M sold.
- 112 institutional investors held GeneDx Holdings (WGS) as of Q4 2021, up from 86 in Q3 2021.
- Funds reported $487M of GeneDx Holdings stock for Q4 2021, down 42% quarter-over-quarter.
- 41 funds opened new GeneDx Holdings positions in Q4 2021 and 15 closed out, a net change of +26 holders.
- The largest GeneDx Holdings buyer in Q4 2021 was Third Point, an estimated $10.2M added.
- The largest GeneDx Holdings seller in Q4 2021 was ARK Investment Management, an estimated $71.3M sold.
Based on aggregated 13F filings for Q4 2021.